What does business segments — consolidated net loss mean?

This represents the total net loss for the entire organization, aggregating all segments and corporate-level expenses. It is the primary measure of the company's overall financial health and its reliance on external financing to sustain operations.

Arbutus Biopharma Corporation ABUS Business Segments — Consolidated net loss

Similar metrics at other companies

ARLOReportable Segment — Consolidated net income (loss)

$14.88M+1,882%

BGCReportable Segment — Consolidated net income (loss)

$83.46M+56.2%

BKSYReportable Segment — Net loss

-$29.66M-132%

TVTXReportable Segment — Net loss

-$37.1M+10.0%

MMIReportable Segment — Net loss

-$3.1M+29.9%

VIRReportable Segment — Net loss

-$125.7M-3.9%

Other financials

Income statement

See full

Revenue$179.1M+10,055%

Operating income$168.9M+757%

Net income$169.7M+792%

EPS (diluted)$0.87+769%

Balance sheet

See full

Cash & equivalents$23.7M-36.1%

Total debt$631.0K-46.9%

Total equity$260.2M+229%

Total assets$277.2M+137%

Cash flow

See full

Operating cash flow-$8.1M+39.4%

CapEx--100%

Free cash flow-$4.7M+55.0%

Valuation

See full

Market cap$871.14M+32.6%

Enterprise value$848.07M+36.6%

P/E5.4×—

P/S4.6×-98.0×

Profitability

See full

Operating margin81.7%+42.1pp

Net margin84%+43.4pp

FCF margin-281.5%-119pp

Returns & leverage

See full

Return on equity94.7%+65.1pp

Debt / equity0×0.0×

Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidated.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's business segments — consolidated net loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arbutus Biopharma Corporation's business segments — consolidated net loss?: Arbutus Biopharma Corporation (ABUS) reported business segments — consolidated net loss of $169.7K in Q1 2026.
What does business segments — consolidated net loss mean?: This represents the total net loss for the entire organization, aggregating all segments and corporate-level expenses. It is the primary measure of the company's overall financial health and its reliance on external financing to sustain operations.